Data Dictionary: Belgian Cancer Registry: Difference between revisions

Latest revision as of 13:25, 2 December 2025

forresearchers belgiumcountry Go back to Belgium page

Sources - Cancer Diagnosis Variables: Click here to learn more; Screening Variables: Click here to learn more.

Table 1: Cancer Diagnosis Variables.

Unique patient identification including demographic parameters (i.e., date of birth, zip code)
Unique identification of the care program and hospital
Diagnosis according to international classification
Date of incidence
Tumour stage (cTNM)
Conclusion of the pathological report (including pTNM)
Treatment with reference to guidelines or justification of deviation
Follow-up plan
Side effects
Disease-free survival and survival (i.e., treatment outcome)
Date of death
Gender
Region
Incidence year
5-year age group (only for absolute numbers and gross incidence)

Table 2: Screening Variables.

Aspects of Participation and Screening Test Usage
Aspects of participation
Use of the screening test in the target group
Results obtained and their use (including cancer detection rate, sensitivity, and specificity)
Cyto-histopathology register
Results of further follow-up

@@ Line 1: / Line 1: @@
-Source: [https://kankerregister.org/media/docs/downloads/applications/ManuelWBCRv2.1.pdf]
+<span style="display:none">forresearchers</span> <span style="display:none">belgiumcountry</span>
+Go back to [[Belgium]] page
+Sources - Cancer Diagnosis Variables: [https://kankerregister.org/nl/kankerdiagnoses Click here to learn more]; Screening Variables:  [https://kankerregister.org/nl/screening Click here to learn more].
+'''Table 1:''' Cancer Diagnosis Variables.
 {| class="wikitable"
-! Patient's information
-|-
-! Variables
-|-
-| Hospital
-|-
-| Patients' social security number
 |-
-| Name
+| Unique patient identification including demographic parameters (i.e., date of birth, zip code)
 |-
-| Postal code
+| Unique identification of the care program and hospital
 |-
-| Town
+| Diagnosis according to international classification
 |-
-| Country
+| Date of incidence
 |-
-| Number of the insurer
+| Tumour stage (cTNM)
 |-
-| Birth date
+| Conclusion of the pathological report (including pTNM)
 |-
-| Date of death
+| Treatment with reference to guidelines or justification of deviation
 |-
-| Sex
+| Follow-up plan
-|}
-{| class="wikitable"
-! Oncologic Diagnosis
 |-
-! Variables
+| Side effects
 |-
-| Incidence date
+| Disease-free survival and survival (i.e., treatment outcome)
 |-
-| Diagnostic method
+| Date of death
 |-
-| OMS score of the diagnosis
+| Gender
 |-
-| Localization of the primary tumor
+| Region
 |-
-| Tumor's laterality
+| Incidence year
 |-
-| Tumor's histology
+| 5-year age group (only for absolute numbers and gross incidence)
-|-
-| Degree of diferenciation
-|-
-| Clinic TNM
-|-
-| Pathologic TNM
-|-
-| Other clinic classifications
-|-
-| Start date of first treatment
-|-
-| Treatments already received
-|-
-| Subsequent plan of treatment
 |}
+'''Table 2:''' Screening Variables.
 {| class="wikitable"
-! Oncological Follow-up
-|-
-! Variables
-|-
-| Incidence date
 |-
-| Localization of the primitive tumor
+| Aspects of Participation and Screening Test Usage
 |-
-| Tumor's histology
+| Aspects of participation
 |-
-| Occurrence of free interval
+| Use of the screening test in the target group
 |-
-| Date of first recurrence
+| Results obtained and their use (including cancer detection rate, sensitivity, and specificity)
 |-
-| Plan of subsequent treatment
+| Cyto-histopathology register
 |-
-| Justification of the follow-up
+| Results of further follow-up
 |}